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Low-complexity regionsa b s t r a c t
In recent years, attention has been devoted to proteins forming immiscible liquid phases within the liquid
intracellular medium, commonly referred to as membraneless organelles (MLO). These organelles enable
the spatiotemporal associations of cellular components that exchange dynamically with the cellular
milieu.
The dysregulation of these liquid–liquid phase separation processes (LLPS) may cause various diseases
including neurodegenerative pathologies and cancer, among others.
Until very recently, databases containing information on proteins forming MLOs, as well as tools and
resources facilitating their analysis, were missing. This has recently changed with the publication of 4
databases that focus on different types of experiments, sets of proteins, inclusion criteria, and levels of
annotation or curation.
In this study we integrate and analyze the information across these databases, complement their
records, and produce a consolidated set of proteins that enables the investigation of the LLPS phe-
nomenon. To gain insight into the features that characterize different types of MLOs and the roles of their
associated proteins, they were grouped into categories: High Confidence MLO associated (including
Drivers and reviewed proteins), Potential Clients and Regulators, according to their annotated functions.
We show that none of the databases taken alone covers the data sufficiently to enable meaningful anal-
ysis, validating our integration effort as essential for gaining better understanding of phase separation
and laying the foundations for the discovery of new proteins potentially involved in this important cel-
lular process.
Lastly, we developed a server, enabling customized selections of different sets of proteins based on
MLO location, database, disorder content, among other attributes (https://forti.shinyapps.io/mlos/).
 2021 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Bio-
technology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Eukaryotic cells organize their biological processes through
numerous compartments or organelles which are often surrounded
by a membrane. More recently, attention has been given to other
types of supramolecular assemblies forming membraneless orga-
nelles [17,3,4,28]. Membraneless organelles (MLO) are condensates
formed through liquid–liquid phase separation (LLPS), involving
cellular components that form multivalent interactions andexchange dynamically with the intracellular medium in response
to environmental signals [24,11,70]. MLOs carry out a wide range
of functions enabled by heterogeneous mixtures of proteins and
nucleic acids, such as metabolic processes and signaling pathways
in the cytoplasm and in the nucleus [24,11,70].
Generally, MLOs contain tens to hundreds of macromolecules
[16,31], but only a small subset of these components appears to
be essential for the formation, structural integrity, and function
of the condensate [92,36,45,22]. We refer to proteins that are
essential for the formation of an MLO, and therefore directly or
indirectly important for the function of the condensate, as High-
Confidence (HC) MLO associated proteins. This category of proteins
includes the small subset of proteins that have been assigned the
F. Orti, A.M. Navarro, A. Rabinovich et al. Computational and Structural Biotechnology Journal 19 (2021) 3964–3977role of Scaffolds/Drivers or Co-drivers of the LLPS process, on the
basis of evidence that they undergo LLPS on their own (Scaffold/
Drivers), or in conjunction with another protein or RNA (co-
drivers) [69,27,38]. The remaining majority of the components
are dispensable for MLO formation and often reside in the MLO
only under certain conditions [23,34], although they may be
important for the biological function of the MLO, and hence not
be altogether dispensable for this reason. These proteins are
referred to as Clients and Regulators. Clients are recruited to the
condensate [10,25], whereas Regulators are often not part of the
MLO proper [14,66].
The stability and dynamic properties of MLOs are the result of
multivalent weak interactions between folded domains, intrinsi-
cally disordered proteins (IDP) or regions (IDRs), and interacting
motifs [37].
LLPS is a tightly regulated process, which when perturbed, can
undergo a transition from a physiological liquid condensate to
pathological solid-like protein aggregates, leading to aging-
associated diseases [6,82] and various neurodegenerative patholo-
gies, among which Alzheimer, Parkinson, Huntington, ALS and FTD
diseases stand out [2,18,68,100]. In this work we focus on the nine
most representative MLOs comprising at least 15 associated pro-
teins. Many other cellular condensates have been recently
described in the literature but with fewer associated proteins
[87]. For these representative MLOs, a very short description is
given. The Nucleolus is the largest and better-studied condensate,
it is implicated in rRNA transcription, processing and ribosomal
subunit assembly, and its local protein content is twice as crowded
as the nucleoplasm [78]. The Nuclear speckles are numerous irreg-
ular droplets, located adjacent to the interchromatin regions. They
are enriched in long non-coding RNA in addition to specific pro-
teins [44,21]. Paraspeckles are also located near the interchro-
matin regions and have an active role in gene expression
regulation. The proteins NONO, PCPC1, and PSF are essential for
the formation of these condensates, as is the long non-coding
RNA NEAT1 [32,91]. Cajal-Bodies play an important role in the reg-
ulation of short non-coding RNAs, among which snRNAs of the
spliceosome and snoRNA stand out. Coilin is one of the character-
istic proteins of these bodies [59,57].
PML-Bodies contain various factors associated with a wide
spectrum of functions, such as protein degradation, telomerase
maintenance, and antiviral defense [53,20,61]. The Nuclear Pore
Complex (NPC) is a large macromolecular assembly with a com-
plex composition and diverse functions. Its main function is to reg-
ulate the macromolecule traffic to and from the nucleus and the
cytoplasm, but it is also an active player in the gene expression
pathway [85], chromatin organization and DNA repair [33].
The NPC is formed by a shell of well structured densely packed
proteins , [95,13], but the natively unfolded phenylalanine – gly-
cine rich (FG) segments of Nup proteins (FG-Nup), is what creates
a liquid phase separated milieu at the center of the transport chan-
nel, a property that is deeply conserved [71,79,43]. The functional
feature of the NPC – the permeability barrier – is made entirely of
these FG repeats at the disordered region of the proteins, which
readily phase separate. Importantly, macromolecules that are
unable to interact with the disordered FG motifs of Nup are pre-
vented from crossing the NPC [19,63]
Among the most relevant cytoplasmic MLOs are the Stress
Granules and the processing bodies (P-body). Stress Granules
are formed in response to various cellular stress signals, among
their functions are inhibition of translation initiation and polysome
disassembly. Stress Granules are formed by a group of RNA-
binding proteins, binding to 80 rf-mRNA complexes that separate
in a different liquid phase [48]. The P-bodies are a ubiquitous
MLO conserved in eukaryotic cells, containing proteins involved
in RNA turnover regulation. The accumulation of non-translating3965RNAs by translation inhibition is correlated with an increased
number of p-bodies in the cell [58]. Postsynaptic densities (PSD)
are membrane semi anchored, protein-enriched cellular compart-
ments in close contact with the postsynaptic membranes. The Syn-
GAP and PSD-95 proteins, in almost stoichiometric concentration
form a multivalent complex that leads to the liquid–liquid phase
separation in highly concentrated droplets in dynamic exchange
with the free proteins in the cytoplasm [101].
Until very recently, databases with detailed and reliable infor-
mation on LLPS proteins as well as tools and resources facilitating
the study of their function and behaviour, were not available.
Recently, four LLPS-dedicated databases partially addressing this
need became available: PhaSePro [62], PhasepDB [98], DrLLPS
[66] and LLPSDB [55]. Each of these databases archives a different
set of proteins and focuses on different aspects such as the bio-
physical processes, LLPS assembly, MLO localization, protein distri-
bution across MLOs and biological function. The experiments
required to include a protein in the databases and the level of cura-
tion also differ considerably within and between databases.
The first goal of this work is to analyze the content of these
databases despite their different structure, annotation and curation
level. To this end we collated and complemented their records and
produced a consolidated and curated set of proteins enabling a
broader investigation of the LLPS phenomenon. The second goal
is to identify features such as disorder content, low complexity
regions, among others, in different groups of LLPS-associated pro-
teins and correlate them with their function and distribution
among MLOs. Lastly, we developed a web server (https://forti.shi-
nyapps.io/mlos/) collating records from the 3 databases offering
the scientific community easy means of retrieving sets of proteins
filtered by specific criteria (localization to specific MLOs, source
database, disorder content, etc.). We show that none of the cur-
rently available LLPS databases, taken alone, contains sufficient
information to enable a general overview of the roles of LLPS asso-
ciated proteins in the process of condensate formation, the various
features of these proteins and the relations with their biological
function and distribution among MLOs.2. Material and methods
2.1. Databases
PhaSepPro [62]: is a manually curated database of LLPs driver
proteins in various organisms, with emphasis on the biophysical
properties that govern phase separation. It contains information
on 121 proteins, and on 144 LLPS driving regions mapped onto
these proteins and refers to 315 publications to support their pro-
tein classifications.
PhaSepDB [98]: classifies proteins into three groups depending
on the origin of the data: (1) Reviewed, where each protein has
proven LLPS association by at least one of the following assays: i)
reconstitution of the liquid condensate with purified components
in vitro, ii) in vitro or in vivo fluorescence recovery after photo-
bleaching (FRAP), iii) droplets formation in vivo revealed by
immunofluorescence with a fluorescent marker. (2) Uniprot
Reviewed, proteins annotated in Uniprot as associated with mem-
braneless organelles, subsequently verified using the same criteria
as for the reviewed set and (3) High-Throughput, comprising pro-
teins identified by High-throughput (HT) techniques applied to
MLOs, such as Organelle purification, proximity labeling,
Immunofluorescence image-based screen and affinity purification.
As of October 2019, PhaSepDB includes 2957 proteins.
DrLLPS [66]: proteins in this database are classified as Drivers,
Regulators and potential Clients. Drivers are defined as the drivers
of LLPS, essential for the formation of the MLOs and the major com-
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LLPS. Potential Clients are defined as proteins identified to be in
complex with known Scaffolds by conventional biochemical assays
or mass spectrometry, or localized to an MLO by immunofluores-
cence, while Regulators are proteins that modulate the LLPS of
Scaffold proteins and/or the stability and dynamic properties of
the MLO. DrLLPS (latest update on 10 June 2019) contains informa-
tion on 150 Scaffold proteins (LLPS drivers), 987 Regulators, and
8148 potential Client proteins. These proteins are assigned to 40
biomolecular condensates.
The fourth DB, LLPSDB [55], is entirely dedicated to in vitro
LLPS experiments, most commonly using purified proteins and
tightly controlling the biophysical conditions of droplet forma-
tion, such as different buffer solutions, crowding agents, protein
concentration, temperature [15,29]. Although the database has
valuable information about the proteins, these LLPS processes
may not be representative of the phase separation process and
MLO composition under physiological conditions. Also, the data-
base does not provide information about MLO localization of
the proteins. We nevertheless evaluated the overlap between
the proteins stored in LLPSDB and those in the other three data-
bases. This showed 75 of the 91 (82%) human proteins of LLPSDB
to be redundant with those in the other 3 databases, of which 65
are LLPS Drivers. The 16 proteins unique to the LLPSDB lack anno-
tations to specific MLOs, including in Uniprot, justifying their
exclusion from our analysis. (for details, see Fig. S1 and
Table S1 of the Supplementary Material). For these reasons our
analysis is limited to proteins in the PhaSePro, PhaSepDB and
DrLLPS databases.
The contents of the 3 databases and their annotations were
downloaded from the corresponding servers and their information
was merged, completed and stored in a local database. For each
protein we added information from Uniprot [84], domain informa-
tion from PFAM [30], disorder content from MobiDB 3.0 [74] and
post-translational modification information retrieved from Phos-
phoSitePlus [41]. Prion-Like domains (PLD) of human proteins
were predicted by PLAAC using defaults parameters and a relative
weighting of background frequencies (a) of 50% from Homo Sapi-
ens [5].
Data was downloaded, processed and plotted, using Python 3.7
scripts; graphs were prepared with Matplotlib and Seaborn Python
libraries.
The consolidated dataset is freely available to the scientific
community (https://forti.shinyapps.io/mlos/) allowing users to
select proteins based on criteria such as disorder content (DC),
Low-Complexity (LC) regions, database source among others. For
example querying for proteins featuring LC regions, retrieves a list
of 1200 proteins for further analysis. Proteins can be retrieved
using a combination of criteria such as, being from humans, con-
taining > 50% of disordered residues, having at least one RNA bind-
ing domain and a LC region of at least 100 residues. Applying these
filters retrieves a group of 8 proteins (FUS, SFPQ, SRRM1, SRSF2,
TAF15, RBM25, SLTM and SRSF8) from which the first 5 are of
the Driver category.
2.2. Proteins are grouped into 3 categories based on the available
annotations
For the purpose of the analysis the human proteins collated
from the different databases are grouped into 3 categories on the
basis of the annotations provided in the corresponding databases
about their roles in the formation and integrity of the MLOs. Defin-
ing these roles relies heavily on the interpretation of LLPS experi-
ments reported in the supporting literature. This is a challenging
task for which agreed-upon practices are still lacking. Our division3966should therefore be considered more as work in progress, reflecting
the current status of the field.
In the following we describe the criteria used to define the 3
protein groups. The so-called High Confidence (HC) MLO associ-
ated proteins include: 1) 101 proteins with direct supporting evi-
dence of their driver and/or Co-driver role in the LLPS process,
consolidated from 59 proteins contributed by PhaSePro [69,27],
and 76 proteins by the DrLLPS database [66], 2) 490 reviewed pro-
teins from PhaSepDB [98]. The latter proteins are not directly
annotated as having direct experimental evidence supporting their
role in driving LLPS, but are annotated in PhaSepDB as proteins
whose role in MLO formation has been ‘reviewed’ or ‘Uniport
reviewed’ by mining NCBI PubMed with appropriate keywords
and by examining the full text of the publications for supporting
evidence (detailed in section 2.1).
The Potential Clients group proteins with weaker supporting
evidence on their participation in MLOs, since the information on
their role is derived from high-throughput (HT) experiments. Pha-
SepDB contributes 1303 proteins detected in such experiments,
and DrLLPS contributes 3176 proteins to this group. Both sets
add up to 3209 non-redundant proteins, which for the sake of sim-
plicity also be referred to as Clients in this study.
The Potential Regulators comprise proteins annotated as regu-
lating the formation of the MLO or their stability, with no evidence
for their incorporation into the MLO proper, while capable of
changing the MLO morphology or function under certain circum-
stances. PhaSepDB and DrLLPS add up to 930 proteins to this cate-
gory (also referred to as Regulators for simplicity sake). An
overview of the consolidated datasets is presented in Fig. 1.
A protein may be annotated as a Driver in one MLO in one data-
base, on the basis of its annotated scaffolding role, and as Client or
Regulator in another, because of its HT recruitment. In such a case
it is considered as a Scaffold for the purpose of the analysis as HT
recruitment is a weaker evidence to assign a role. Also, as several
experiments are often reported for each MLO type, a given protein
can be assigned to two or three categories depending on the MLO.
For example CPEB3 is reported to act as a Scaffold in P-bodies and a
Client in Stress Granule. This is why there is an overlap between
datasets shown in the Results section.
All the measured parameters are compared with a control
dataset, which is the Human Proteome from Swiss-Prot (20.349
proteins).3. Results
3.1. Databases overview
An integrative analysis of LLPS proteins and MLOs is challenging
due to several reasons: the different sets and number of proteins
and different focus and scope of individual databases, data struc-
tures, associated metadata, different experiments used to obtain
the data and different curation level, among others. For example,
PhaSePro contains a small number of proteins at a high curation
level; DrLLPS, has different datasets depending on the role of the
protein within the MLO, the supporting evidence and the curation
level. PhaSepDB has less metadata and offers several data sets
depending on the experimental method that are relied on to gen-
erate the annotation, this database emphasizes proteins localiza-
tion more than their function in the LLPS process.
The organism coverage among the databases is also different:
49% of PhasePro, 83% of the low-throughput (LT) and 75% of the
HT of PhaSepDB proteins are from humans, while in DrLLPS human
Clients and Regulators proteins represent<40% of the proteins.
Other organisms (non-human) are less well represented with no
Fig. 1. General databases overview. A) distribution of entries by organisms in the databases. B) Venn diagram illustrating the overlap of the proteins stored in the different
databases. Overlapped regions indicate the number of shared proteins; othewise, they are unique to a database.
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databases (Fig. 1A and Suppl. Table 2).
Due to these differences, only 56 out of a total of 10,698 pro-
teins are shared between all three databases: 42 human proteins
out of 4367 and 14 non-human proteins out of 6331 (Fig. 1 B). This
highlights the need to consolidate the data from the different data-
bases in order to obtain a general overview and gain knowledge on
the proteins engaged in LLPS and their functional role in MLOs.
3.2. Human proteins
Taking into account that human proteins make up the majority
of the data, and that there is an incomplete and heterogeneous rep-
resentation of the organisms in the databases, compounded by the
intrinsic differences between organisms, the study of the MLOs
across different organisms is not feasible at this point. We there-
fore focus our analysis on human proteins.
To overcome the inconveniences due to the different character-
istics of the databases, we merge, unify and complete the informa-
tion (whenever possible) and group the proteins into new
augmented biologically relevant data sets of MLO associated pro-
teins suitable for further analysis. These proteins are subdivided
into three groups: High Confidence MLO associated, Clients and
Regulators, as described in Material and Methods section. Fig. 23967shows the composition of the datasets in these 3 groups and pro-
tein distribution within MLOs; the number of proteins that each
database contributes to individual MLOs is listed in Suppl. Table 3.
Considering the large number of organelles described in the lit-
erature, of which many comprise only a few associated proteins,
we focus on the 9 most representative MLOs, defined as those hav-
ing at least 15 highly curated proteins in HC MLO associated pro-
teins dataset. The remaining MLOs are clustered in this work
under the label of ‘‘Others”.
Our analysis first investigates the HC MLO associated set of pro-
teins, as these are the best annotated and considered as essential
constituents of the MLOs. This set of proteins is then compared
with the Clients and Regulators sets. The following results are for
the HC MLO associated set of proteins unless specified otherwise.
Few HC MLO associated proteins are present in all 3 databases,
as expected, these proteins are well characterized as LLPS drivers
or co-driver within the corresponding MLOs [69,27]. For example,
this is the case of proteins like MAPT, HNRNPA1, TARDBP and
FUS in paraspeckles [78], with FUS being also present in Stress
Granules (SG) [24]. Suppl. Fig. 2 and Suppl. Fig. 3 displays the dis-
tribution of human proteins from the 3 different groups among the
different MLOs, and the source databases.
To shed light on the composition and function of individual
MLOs, in the following we analyze the shared proteins between
Fig. 2. A) Dataset compositions for the 3 groups of human proteins and the corresponding protein distribution among MLOs. The total number of proteins in each group and
number of proteins within each MLO are listed. Numbers in brackets denote confirmed non-redundant Scaffold/Driver proteins. B) Total number of HC MLO associated,
Potential Client and Regulator proteins respectively, in our consolidated dataset. C) Overlap of the proteins from the three groups. Note that some proteins play a diving/
scaffolding role in one MLO while acting as Client in another MLO.
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tent, content of low complexity regions and post-translational
modifications (PTM).
3.3. Distribution of HC MLO associated, Clients and Regulator proteins
in individual MLOs
Proteins common to two MLOs range from 20 to 60% except for
the NPC that has only one protein (NUP98) in common with SG (1
out of 24 proteins). Half of the proteins present in P-bodies are also
in SG, whereas SG shares 30% of its proteins with P-body. SG pro-
teins are also present in many other MLOs as: Nucleolus, Nuclear
Speckles and Paraspeckles (Suppl. Fig. 4).
Examples of proteins that are present in several MLOs, include
FUS, EWSR1, HNRNPA1 and XPO1 present in almost 6 MLOs and
DDX1, DDX3X, HABP4, HNRNPA2B1, KPNB1, TAF1 and TARDBP in
almost 5 (Fig. 3 A). Not surprisingly, most of these proteins are dri-
vers or co-drivers and are also present in all three databases.
The studied MLOs do not have the same proportion of proteins
in each of the 3 protein groups, nor the same level of protein anno-
tations. >60% of the proteins in Paraspeckles and Nuclear Speckles
are HC MLO associated (of which several are drivers or co-drivers),
whereas proteins of this set represent <10% of the proteins in P-
bodies and SG. An extreme case is PSD with 95% of its proteins
being Clients. In fact, all the proteins of PSD were detected in one
experiment [12] and are annotated as Clients in DrLLPS (Fig. 3 B).
On the other hand, NPC has exclusively HC MLO associated proteins,
one of them (NUP98) is an LLPS Driver (see Discussion section).39683.4. Disorder content
The role of disordered proteins and regions in driving LLPS has
been amply documented for driver proteins in the nucleolus [15],
SG [93], Paraspeckles [39] and P-bodies [26], among others [78].
The amino acid composition of the disordered regions of our set
of HC MLO associated proteins agrees with previous reports [76].
Cysteine, Isoleucine, Phenylalanine, Leucine and Valine are
under-represented, while Glutamine, Arginine, Serine, Glycine
and Proline are over-represented. However, discriminating by
MLO allows us to observe sizable differences that may have a bio-
logical meaning and deserve further investigation (Suppl. Fig. 5 A).
It was shown that LLPS proteins have on average a higher disor-
der content (DC) than other proteins [78]. In agreement with this
observation, our HC MLO associated set of proteins has a signifi-
cantly higher disorder content (DC) than the Human proteome
from Swiss-Prot, taken as reference, yet HC MLO associated proteins
still exhibit a wide range of disorder content across MLOs (Fig. 4 A).
Proteins in the Nucleolus, Nuclear Speckles, SG, Paraspeckles
and P-bodies are significantly more disordered than human pro-
teins in Swiss-Prot. The median DC of PML-bodies, Cajal-bodies
and PSD proteins is higher than those of the Swiss-Prot reference,
albeit not significantly.
On the other hand, the median DC of NPC proteins is below that
of the human proteome on the basis of currently available data in
the LLPS protein databases: 1 driver protein from PhaSePro -
Nup98- and 23 proteins from PhaSepDB. This result reflects the
fact that the NPC, taken as a whole, has well structured densely
Fig. 3. Landscape of Protein distribution among MLOs. A) HC MLO associated proteins present in more than one MLO are colored blue. When in addition a protein is also
annotated as a Client or Regulator in another MLO, it is colored green and red respectively (Y axis: proteins; X axis: MLOs. B) Proportion of proteins of a given category in
different MLOs. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 4. Disorder content. A) Disorder content (DC) distribution by MLO. (*) indicates that there is a significant difference (Kruskal-Wallis test, p-value < 0.05) with respect to
the control set of proteins (swiss-prot); B) DC distribution vs the number of MLO where the protein is present. The DC in the 3 ranges (1, 2 and > 2 MLOs) are significantly
different from the control. The DC being in 1 and 2 MLOs is also significantly different (Kruskal-Wallis test, p-value < 0.05, denoted by a *); C) Disorder content by protein sets
(drivers are individualized for comparison purposes).
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teins [51,40].
The DC of Clients and Regulators in individual MLOs is lower
than the DC of the HC MLO associated proteins except for PML bod-
ies and cajal-Bodies where Regulators have the highest DC (shown
in Suppl. Fig. 6).
When classifying our set of proteins by High (DC >70%), Middle
(30> DC <70%) and Low (DC <30%) disorder content, the propor-
tions are different between MLOs (Suppl. Fig. 7). Except for PML-
body and NPC, all the organelles have >50% of their proteins with
middle and high DC. Extreme DC values are found for Paraspeckles
and Nuclear Speckles with almost 80% of their proteins having high
DC and for NPC, which exhibits the lowest number of proteins with
medium or high DC (around 20%).
An interesting result is that the more different MLOs a protein
takes part in, the higher the DC content of that protein, i.e more
disordered proteins are found in more MLOs. This might suggest
a predominant and similar role of these proteins in the different
MLOs (Fig. 4 B) (See also suppl. Table 4, on proteins with >70% of
disordered residues and their location).
Lastly, the DC is also different across the HC MLO associated, Cli-
ents and Regulators sets of proteins. The DC of HC MLO associated
proteins differs significantly from that of the control human pro-
teome, while those of Clients and Regulators do not (Fig. 4 C. The
DC of the Driver set of proteins alone is also shown for
comparison).39703.5. Low complexity regions
A special case of disordered regions are low complexity regions
(LC), where the amino acid composition is biased toward a handful
of amino acids, sometimes to a single one or a few. There are 579
LC regions belonging to 261 proteins in the HC MLO associated
group, 83% of them overlap with the disordered regions. (Suppl.
Table 5 contains all the LC regions of the entire dataset).
A striking example of a composition bias in LC regions, is the
protein FMN2_HUMAN (formin 2), which has 339P in 29 identical
repetitions of a (P)4LPGAGI motif (in a 511 amino acid long P rich
region). Formin 2 controls the cyclin-dependent kinase inhibitor
p21 protein levels by forming a complex and preventing its degra-
dation [96]. Formin 2 acts as an actin nucleation factor and pro-
motes assembly of actin filaments together with SPIRE1 and
SPIRE2. It also plays an active role in responses to DNA damage,
cellular stress and hypoxia and in the vesicle transport along actin
fibers [89,72]. Formin 2 is annotated as ‘‘reviewed” in PhaSepDB,
and hence is a HC MLO associated protein in the nucleolus, and is
classified as a potential Client in Postsynaptic Density in the
DrLLPS.
Glycine-rich regions are the most over-represented in our set of
HC MLO associated proteins, followed by Proline rich regions (Fig. 5
A). Arginine, Serine and Aspartic acid are also enriched in LC
regions. Fig. 5 A shows that different MLO have specific
aminoacid-rich regions. For example Glutamine (Q) and Glutamic
Fig. 5. A) Amino acid enrichment in LC regions by MLO in the High Confidence MLO associated dataset. From blue (depleted compared with Swiss-Prot), to red (enriched
compared with Swiss-Prot). Enrichment was calculated as: DeltaFreq = (FreqAA in LC – FreqAA control)/FreqAA control. Green histogram: proportion of proteins having LC
regions (from 0 to 1) by MLO. Dark green denotes the PLD domain proportion within the LC regions while light green shows other LC regions. B) Proportion of protein
containing LC regions in the three categories of proteins (HC MLO Associated, Clients and Regulators). Dark green are proteins containing PLD, RGG or SR motifs (featured LC);
light green, other LC regions; gray indicates non-LC regions. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
Fig. 6. Comparison of the most highly enriched domains in the different set of proteins. The proportion of proteins having RMM_1: RNA binding domain; PLD: Prion-Like
Domain; Helicase_C; DEAD domain, WD40 domain, P-Kinase, zf-RanBP and SH2 domains in the three groups of proteins compared with the control (Swiss-Prot).
F. Orti, A.M. Navarro, A. Rabinovich et al. Computational and Structural Biotechnology Journal 19 (2021) 3964–3977(E) are not enriched in LC regions when considering the full set of
HC MLO Associated proteins (Suppl. Fig. 8), but are remarkably
enriched in P-body and PML-body respectively. Also, the propor-
tion of proteins with LC region varies in the different MLOs
(Fig. 5 A). LC regions are higher in HC MLO associated than in Poten-
tial Clients and Regulators proteins (Fig. 5 B).
Although Fig. 5 shows the enrichment for individual amino
acids, important LC regions feature frequent combinations of resi-
dues: glycine and Arginine (GR), Arginine and Serine (RS) (remark-
ably high in Nuclear Speckles), and Glycine Serine (GS). Serine in
combinations with Aspartic (DS) and Glutamic (ES) are also very3971frequent, mainly in Nucleolus. Within the LC regions, PLD, RGG
and RS motifs deserve a separate analysis as they make up the
majority of our annotations and are strongly associated with LLPS
and MLOs (Table 1 shows the proteins with PLD, RS-rich and P-rich
regions and the MLO where they are present). They are mostly RNA
binding and protein-protein interactions motifs [86,83,90].
Glycine rich regions are frequently associated with LLPS,
because they are part of the so-called Prion-Like domains (PLD).
PLD domains in the FET family of proteins (FUS, EWSR1 and
TAF15), responsible for driving phase separation in vivo and
in vitro [86,83,90], are enriched in G, Y, Q and N residues.
Fig. 7. A) Boxplot of the PTMs annotated to each protein by groups (between brackets are the number of proteins that have at least 1 PTM in the set); the PTMs annotated to
proteins in Swiss-Prot are used as reference. B) Disease-associated PTMs, by groups. C) PMTs associated with regulatory functions, by groups.
Table 1
High-confidence MLO associated proteins with LC regions and their localization across the MLOs.
MLO Prion-Like Domain TriRGG regions RS-rich regions Proline-Rich regions (PRM)
Nucleolus HNRNPD, RBM14, TAF15, PSPC1,
HNRNPA2B1, HNRNPH1, HNRNPH3,
FUS, EWSR1, POLR2A, HNRNPA1L2,
HNRNPA1, ILF3, DDX17, HNRNPA3,








ARL6IP4 CEBPA, CHD7, DDX17, DROSHA, EWSR1,
FMN2, KDM6A, NOL3, PELP1, PHF2,
PHLDA1, POLR2A, SIN3A, TP53, ZNF207
Nuclear
Speckles
PSPC1, HNRNPA2B1, FUS, EWSR1,




NCBP1, SRSF10, SRSF2, SON, U2AF2,
SRRM1, AKAP17A, ARL6IP4, SRRM2,
SRSF1, SRSF6, SRSF3, PNISR, PPIG,
CDK13, DDX46, ZNF638, SRSF4, CCNL2,
BCLAF1, THRAP3, CCNL1
AKAP8L, ATOH8, ATXN2L, CASC3,
CBLL1, CBX4, CCNT1, CDK13, CEBPB,
CPSF6, EAF1, EWSR1, HNRNPU, KMT2E,
MAML1, MAML2, PABPN1, PNISR,
RBM15, RBM15B, RING1, RREB1,
SETD1A, SETD1B, SF3B2, SMARCA2,
SMARCA4, SON, SRRM1, SRRM2, WT1
Stress
Granule
HNRNPD, TAF15, PSPC1, HNRNPA2B1,
HNRNPH1, HNRNPH3, DAZAP1, FUS,
EWSR1, ATXN2, TARDBP, YTHDF2,
HNRNPA1, UBQLN2, YTHDF1, ATXN2L,






– ATXN2, ATXN2L, CASC3, CPEB2, CSTF2T,
DAZAP1, DVL2, EIF4G1, EWSR1, G3BP1,
PUM1, RC3H2, TNRC6B, YTHDF1,
YTHDF2, YTHDF3, ZFP36
P-Body TAF15, HNRNPA2B1, DAZAP1, FUS,




– ATXN2L, CPEB3, CSTF2T, DAZAP1, EIF4E,
EWSR1, G3BP1, MEX3A, PAN3, TNRC6A,
TNRC6B, YTHDF1, YTHDF2, YTHDF3,
ZFP36
Paraspeckles RBM14, TAF15, HNRNPUL1, PSPC1,
SFPQ, HNRNPH1, HNRNPH3, DAZAP1,







CPSF7, SRSF10, RBMX AHDC1, AKAP8L, CPSF6, CPSF7, DAZAP1,
EWSR1, FIGN, HNRNPK, HNRNPR,
HNRNPUL1, MEX3C, NONO, PCED1A,
RBM12, RBMX, SFPQ, SMARCA2,
SMARCA4, SOX9, TP53, UBAP2L,
ZNF335
PML-Body ATRX – – AKAP8L, RPA1, SATB1, SMARCA4,
THAP1, TP53
Caja- Body TARDBP FBL, HABP4 DDX46 EAF1, ICE1, SMN1
PSD SYN1, HNRNPA1 HNRNPA1 – SHANK3, SYN1, SYN2, SYNGAP1, WAS
Other BRD4, HNRNPD, SYN1, TAF15,
HNRNPA2B1, DAZAP1, FUS, EWSR1,
POLR2A, SP1, TARDBP, YTHDF2,
HNRNPA1, YTHDF1, , HNRNPU,







RBMX BRD4, CBX2, CCNT1, CPEB2, CSTF2T,
DAZAP1, EWSR1, G3BP1, HNRNPU, HTT,
KHDRBS1, POLR2A, RBMX, SOS1, SYN1,
SYN2, TNRC6A, TNRC6B, TP53, WASL,
YTHDF1, YTHDF2, YTHDF3, ZNF207
Important types of LC regions in Drivers proteins: PLD, RGG and RS. Gene name of the proteins and MLO where they are present. barrier
F. Orti, A.M. Navarro, A. Rabinovich et al. Computational and Structural Biotechnology Journal 19 (2021) 3964–3977The dataset of HC MLO associated proteins has 56 members with
PLDs distributed among different MLOs (Suppl. Fig. 9). Twenty two
out of the 56 proteins with PLD domains are located in more than
one MLO, with examples such as FUS and EWSR1, which are pre-
sent in 5 MLOs.
A particularly important type of G-rich region to drive transition
events is the one characterized by having two or three neighboring
RGGmotifs separated by 0–4 residues (RGG(X0–4)RGG(X0–4)RGG)3972[29,83]. In our HC MLO associated set of proteins, 21 have an RGG
motif (two or three RGG repetitions). Proteins with RGG repetitive
motifs are associated with a large number of functions related to
RNA processes, such as transcription modulation, splicing, export
and translation.
Another important motif in our dataset is the proline-rich
motif (PRM) that upon interaction with SH3 domains promotes
droplet formation. We found 97 proteins with P-rich regions
F. Orti, A.M. Navarro, A. Rabinovich et al. Computational and Structural Biotechnology Journal 19 (2021) 3964–3977within the HC MLO associated, 287 in the Potential Clients and 91 in
the Regulators sets of proteins.
Nuclear speckles have an enrichment in Serine and Arginine
proteins (SR-proteins) that also play various roles in RNA process-
ing, such as splicing activation and repression, mRNA export and
translation. The SR family of proteins have SR rich regions and
RNA binding domains that allows it to interact with RNA [86]. In
humans, the SR protein family is encoded by nine genes, named
splicing factors arginine serine-rich (SFRS) [99]. The HC MLO asso-
ciated set of proteins has the SFRS 1,2,3,4,6 and 10 in nuclear speck-
les, SFRS10 is also present in paraspeckles. (Table 1).
3.6. Mlos domain enrichment
In addition to disordered and LC regions, we also mapped the
Pfam domains to every protein in our dataset to analyze domain
composition and distribution by MLO. Prion-like domains (PLD),
as such, are not annotated as Pfam domains, so these domains
were predicted using PLAAC software [5].
First, we analyzed domain enrichment in Driver proteins vs
Swiss-Prot (exact fisher test, p-value < 0.05). Eighty two domains
showed enrichment from which we selected the following 14
domains present in at least 5 proteins: RNA binding domain
(RMM_1, PF00076), PLD, Helicase_C (PF00271), DEAD domain
(PF00270), WD40 (PF00400), LSM Domain (LSM, PF01423), Zn-
finger (zf-RanBP, PF00641), HMG_box (PF00505), SAP (PF02037),
FHA (PF00498), MMR_HSR1 (PF01926), zf-CCCH (PF00642) and
zf-CCHC (PF00098).
RNA binding and PLD domains remarkably predominate in HC
MLO associated proteins, followed by helicase-3, dead and W-40
domains. RRM_1 is the largest group of eukaryotic RNA-binding
proteins and is associated with a variety of RNA related functions.
Several studies point out that in the FET family of proteins the
interaction of RRM_1 and PLD domains regulates liquid-liquid sep-
aration [90]. Such is the case of FUS, where multivalent interac-
tions among tyrosines from prion-like domains and Arginines
from RNA-binding domains drives phase separation [90]. FUS
phase behavior is also regulated in part by the phosphorylation
of serine residues in the PLD domain that control physiological
assembly preventing pathological aggregation [64]. Twenty seven
proteins of the HC MLO associated set contain both domains (PLD
plus RRM_1): CELF4, CSTF2, CSTF2T, DAZ1, DAZ3, DAZ4, DAZAP1,
EWSR1, FUS, HNRNPA0, HNRNPA1, HNRNPA1L2, HNRNPA2B1,
HNRNPA3, HNRNPAB, HNRNPD, HNRNPDL, HNRNPH1, HNRNPH2,
HNRNPH3, PSPC1, RBM14, SFPQ, TAF15, TARDBP, TIA1, TIAL1.
RRM_1 and PLD are the more enriched domains in the Nucleo-
lus, Nuclear Speckles, SG, P-Body and Paraspeckles. On the other
hand, PML-Body and NPC are the only MLOs lacking RRM_1
domains, whereas NPC is the only MLO with no PLD nor RRM_1
domains, although these types of domains are present in NPC’s of
other species [1,35].
Helicase_C and DEAD domains are present in the DEAD Box fam-
ily of proteins. DEAD box helicases are involved in various aspects
of RNA metabolism, including nuclear transcription, pre mRNA
splicing, ribosome biogenesis, nucleocytoplasmic transport, trans-
lation, RNA decay and organellar gene expression [24].
Helicase_C and DEAD domains are present in: ASCC3, BLM,
DDX1, DDX17, DDX18, DDX21, DDX27, DDX31, DDX3X, DDX4,
DDX46, DDX47, DDX5, DDX6, DHX33, DHX36, EIF4A3, MTREX,
WRN. These proteins are associated with several functions includ-
ing ribosomal biogenesis (ej DDX27), mRNA processing (ej DDX3X,
DDX46) and translation repression (ej DDX6) [47].
WD40 domains are formed by a variable number of WD40
repeats. WD-repeats proteins are a large family found in all
eukaryotes, implicated in signal transduction and transcription
regulation, cell cycle control and apoptosis. Proteins containing3973WD40 repeats serve as platforms that coordinate multi-protein
complex assemblies, where the repeating units serve as a rigid
Scaffold for protein interactions and are mediators of transient
interplay among other proteins [46,80]. An example are the
WD40-repeat WD40 containing proteins in the Drivers dataset:
are AAAS, DCAF13, FBXW7, GEMIN5, PLRG1, PWP1, RACK1, RBBP4,
SEC13, UTP4, WDR12, WDR18, WDR36, WDR43, WDR74, WRAP53.
zf-RanBP (RanBP2-type Zinc Fingers) are zinc finger RNA-
Binding motifs found in the E3 SUMO-protein ligase RanBP2
(RANBP2, also called Nucleoporin Nup358) and other proteins.
RANBP2, located at the tip of the cytoplasmic fibrils of the NPC
has a repetition of 8 zinc finger domains [97]. This nucleoporin
binds single-stranded RNA and DNA [94], is a component of the
nuclear export pathway [88] and in the sumoylation pathway
[73] among other functions. RanBP2-type zinc fingers recognize
single-stranded RNA (ssRNA) in a sequence-specific manner which
is an important aspect of gene regulation that modulates mRNA
processing [65]. Other proteins having zf-RanBP domains in our
set of HC MLO associated proteins are FUS, EWSR1, NUP153 and
TAF15 in Stress Granule, YAF15 in Nucleolus and MDM2 in PML-
Body. Among the Potential Client proteins, RBM10 in P-Bodies,
and YAF2 in the Nucleolus both contain zf-RanBP domains, and
so does the Regulator protein RANDBP in P-Bodies.
PML-Body, Cajal-Body, NPC and PSD proteins have a more
diverse set of domains. But since fewer proteins are currently asso-
ciated with these MLOs, this observation needs to be verified as
more data become available.
Taken together, the above observations show that the HC MLO
associated set of proteins are strongly enriched in RNA binding pro-
teins that are involved in the many RNA related processes across all
the analyzed nuclear or cytoplasmic MLOs.
Next, we compare the proportion of the top 6 enriched domains
in HCMLO associated proteins to those in the other 2 protein groups
(Fig. 6). We find that RRM1, PLD, Helicase_C, DEAD, DW40 and zf-
RanBP domains are enriched, in decreasing proportion, in the HC
MLO associated set of proteins, WD40 and RMM_1 domains are also
enriched in Potential Client proteins, although their enrichment is
lower than in HC MLO associated. We studied the proportion of two
other domains due to their enrichment in Potential Client and Reg-
ulator proteins: P_Kinase and SH2. The Kinase domain is remark-
ably enriched in Regulator proteins, agreeing with the regulatory
function of the protein Kinases, also highlighting the importance
of the PTMs (in this case phosphorylation) in the MLO regulation.
The proportion of Kinase domains is likewise higher in Potential
Clients than in HC MLO associated (Fig. 6).
3.7. Post-translational modifications
Previous studies have shown that certain Post-translational
modifications (PTMs) regulate the structure and function of the
MLOs [52,64,75,77,81].
For example, phosphorylation in low complexity regions of FUS
decreases LLPS, preventing aggregation and lowering its toxicity
[64]. On the other hand, TAU phosphorylation increases conden-
sate formation [7], while acetylation reduces it [77]. Furthermore,
some Client proteins are recruited or excluded from certain MLOs
by means of PTMs [25].
We mapped the most frequent post-translational modifications
(PTMs) to the proteins in our dataset: phosphorylation, methyla-
tion, acetylation, ubiquitination sumoylation and glycosylation.
PTMs information was taken from the PhosphoSitePlus database
[42], which stores PTM sites supported by low- and high-
throughput data sources, manually curated by experts from the lit-
erature. Suppl. Fig. 10 shows the number (A) and the most repre-
sented PTMs among MLOs (B) and the function altered by their
Regulatory activity (C). We found that the HC MLO associated,
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taken together have more PTMs per protein than the control
set (Swiss-Prot). HC MLO associated have more PTMs than Potential
Clients and Regulators (Fig. 7 A), and certain MLO’s such as
PML-Bodies, Paraspeckles, SG and NPC have on average more mod-
ification sites than the HC MLO associated’s median
(Suppl. Fig. 10 A).
Several diseases are linked to PTMs in LLPS proteins. Suppl.
Table 6 shows the proteins and the PTMs associated with a disease
pathology. For example MAPT PTMs are linked with Alzheimer’s
disease (AD), chronic traumatic encephalopathy (CTE), Pick’s dis-
ease (PiD), progressive supranuclear palsy (PSP), corticobasal
degeneration (CBD), globular glial tauopathy (GGT), and argy-
rophilic grain disease (AGD), diabetes among others [56,50].
MYC PTMs are associated with acute lymphocytic leukemia,
chronic myelogenous leukemia, leukemia, Burkitt’s lymphoma,
AIDS-related lymphoma, B cell lymphoma, ovarian cancer, breast
cancer, hepatocellular carcinoma [60,49,9]. On the other hand,
FUS phosphorylation in the LC domain decreases phase separation,
preventing the aggregation and reducing its toxicity [64].
HC MLO associated and Regulator proteins have more PTMs
related to diseases than the human proteome and the Client pro-
teins (Fig. 7 B). Regulatory PTMs show a similar trend (Fig. 7 C).
These two observations agree with the driving role and the regula-
tory function of proteins in these groups.4. Discussion
Current LLPS-dedicated databases differ in their focus, annota-
tion and curation levels among other characteristics, making anal-
yses difficult and the extraction of new knowledge challenging.
The goal of our work has been to derive valuable insights into
the landscape of membraneless organelles, their associated pro-
teins, and their functional roles in cell biology. An important con-
tribution of this work was to integrate the available data across
databases, organize the information on LLPS proteins, and enrich
it with complementary functional annotations. The integration
was necessary, because the MLO and protein coverage of individual
databases is different and incomplete, resulting in a limited
amount of shared data across databases. The three databases ana-
lyzed here share only 42 of the 591 HC MLO associated proteins, the
Potential Client and Regulator proteins also have an uneven distri-
bution in the different databases. In addition to conducting the
analysis, we considered it useful to make this integrated and
enriched database available to the scientific community. To this
end, we developed a web server enabling easy retrieval of sets of
proteins necessary for a particular analysis without need to look
for the information in each database. By applying filters on disor-
der content, LC regions, domain content, databases source, among
others, the necessary protein sets can be assembled and all the
associated information retrieved.
The proteins consolidated from the 3 databases were grouped
into three sets: HC MLO associated, Client and Regulator proteins,
on the basis of their level of annotation and their role in the LLP,
to help obtain a general picture of the characteristics of the MLOs
and improve our understanding of these fundamental ultrastruc-
tures and their roles in cellular function.
It is well established that IDR-containing proteins contribute
significantly to the liquid-like character of MLO’s by forming tran-
sient, low affinity multivalent interactions, enabling protein nucle-
ation, assembly and disassembly of the corresponding organelles
[67,78]. Our analysis confirms these observations. We find that
on average, the disorder content (DC) of human proteins in our
HC MLO associated set, is larger than in the human proteome of3974Swiss-Prot, but differs greatly between MLOs. Also, several authors
observe specific biases in domain and sequence composition of
proteins that undergo phase separation [54]. Our results confirm
these biases, but also show that domain composition depends on
the MLO and the functional role of the protein within the MLO.
The HC MLO associated proteins tend to feature multiple functional
modules, including folded domains as well as disordered and LC
regions, thereby creating multivalency, a hall mark of property
for LLPS formation. As confirmed here, this category of proteins is
enriched in RNA- and to a lesser extent in DNA- binding domains
and motifs such as, RRM_1, DEAD, Helicase_C. This highlights the
fundamental role of RNA in MLO formation, stabilization and func-
tion, but very little is currently known about the RNA molecular
composition, structures, and the mechanistic underpinning of its
functional roles. Elucidating the roles of nucleic acids in LLPS pro-
cesses, MLOs dynamics and regulation, is clearly an important
direction for future research.
Post-translational modifications are also prevalent in both HC
MLO associated and Regulator proteins in agreement with their
important role in MLOs fate and the fine tuning of the underlying
regulatory processes, whose malfunction may cause disease.
We find that the disorder content, low complexity regions, as
well as motifs are not predominant across all MLOs, suggesting
that other mechanisms, not involving these features may underlie
the formation, function and stability of certain types of MLOs. As
already mentioned, the NPC is a good example of such MLOs.
Another example is the PSD, whose assembly is driven by the
formation of the SynGAP/PSD-95 complex, which does not involve
protein-interactions mediated by IDRs [101].
The more comprehensive dataset used in our analysis allowed
us to uncover commonalities and differences across MLOs that
would not be brought to light in individual studies, usually per-
formed on reduced and often different sets of associated proteins.
Taken together, the generated information should be a good start-
ing point for future research on a particular protein, protein groups
or specific MLOs.
It is important to note that the categorization of proteins
according to their role in the LLPS process derived from the differ-
ent databases is far from perfect. As such, it reflects the currently
limited information available in the literature about many MLO’s
and their precise cellular components, and how the latter are mod-
ified in different cellular states. This in turn is mirrored by the
sparse and incomplete annotations in the source databases, a situ-
ation that is however bound to change. With the flurry of publica-
tions reporting studies on well known or new experimentally
verified LLPS systems, new information on proteins playing key
roles in these systems is accumulating fast. A good example is
the XPO1 protein, only recently assigned the role of Client in the
NPC, mediating the transport of >200 proteins [8], and is therefore
not annotated as such in the databases.
In addition, much of what we know about MLOs and have been
able to analyze so far, is derived from organelles in human cells,
leaving a gap in our knowledge of equivalent systems in other
organisms. We expect however, that many of the trends observed
in the present study should hold in organisms across the Eukary-
otic kingdoms, and conversely, that the information obtained on
MLOs from other organisms should be valuable in interpreting
the data on human MLOs. But extracting meaningful biological
knowledge from analyzing these systems will require deriving
community-wide guidelines for defining MLOs in terms of the
molecular players involved, their roles in the LLPS process and
their biological functions. These guidelines should form the basis
for a controlled vocabulary that would help standardize informa-
tion retrieval and database annotations in this fast developing
field.
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